Enhancing immunotherapy for CLL patients with ibrutinib
Starving CLL cells of oxygen results in a new predictive test
Lenalidomide and ibrutinib: do they have a future in treating CLL?
Exploring and consolidating the CLL world
Prof. Rule’s data highlights from ICML 2017